Christine M. Ho

Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells

Brian Ruffell, Debbie Chang-Strachan, Vivien W. Chan et al. · Cancer Cell · 2014 · 988 citations · Full text

Life Sciences, Immunology, Oncology +14

Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT

Christine M. Ho, Philip L. McCarthy, Paul K. Wallace et al. · Blood Advances · 2017 · 52 citations · Full text

Medicine, Hematology, Immunology +17

Identification of Neurotoxicity after Chimeric Antigen Receptor (CAR) T Cell Infusion without Deterioration in the Immune Effector Cell-Associated Encephalopathy (ICE) Score

Megan M. Herr, George L. Chen, Maureen Ross et al. · Biology of Blood and Marrow Transplantation · 2020 · 40 citations · Full text

Life Sciences, Immunology, Neurology +13

Real-World Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Subgroup Analyses from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry

Daniel J. Landsburg, Matthew J. Frigault, Michael Heim et al. · Blood · 2022 · 22 citations

Medicine, Hematology, Oncology +16

Real-World Efficacy and Safety Outcomes for Patients with Relapsed or Refractory (R/R) Aggressive B-Cell Non-Hodgkin's Lymphoma (aBNHL) Treated with Commercial Tisagenlecleucel: Update from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry

Daniel J. Landsburg, Matthew J. Frigault, Zhen‐Huan Hu et al. · Blood · 2021 · 11 citations

Medicine, Hematology, Oncology +17